Hyperbaric oxygen therapy (HBO) has been used to promote healing of cutaneo
us ulcers secondary to diabetes mellitus, ionized radiation exposure injuri
es, gas gangrene, crush injuries, and necrotizing fasciitis. Despite the be
neficial effects of HBO, there have been conflicting clinical experiences r
eported regarding its efficacy. To evaluate the effects of localized HBO, e
ight patients who were referred to a vascular surgery service with nonheali
ng rheumatoid vasculitic cutaneous ulcers were placed on a regional HBO reg
imen consisting of 100% fraction of inspired oxygen at 2x atmospheric press
ure for 60-90 minutes three times daily. Wound healing occurred in 87.5% of
patients with a mean healing time of 4.7 weeks (range 2-10 weeks). The aut
hors conclude that localized HBO for the treatment of refractory rheumatoid
vasculitic ulcers is a safe and expedient modality to be considered and th
at these chronically hospitalized patients, exhausting other treatment regi
mens, may benefit from HBO therapy.